Drugs / measles vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00244673 Background | Oct 2005 → Dec 2011 | — | Bandim Health Project | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | measles vaccine | “Live vaccines like measles vaccine (MV) seem to protect against overall mortality, whereas killed vaccines, like DTP, may have no beneficial effects, especially for girls.” NCT00244673 ↗ |
| Known as | MV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00244673 ↗ |
| Modality | Vaccine | “Live vaccines like measles vaccine (MV) seem to protect against overall mortality, whereas killed vaccines, like DTP, may have no beneficial effects, especially for girls.” NCT00244673 ↗ |